Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
NCT Number: NCT02055534
Poor nutritional status is common in patients with systemic immunoglobulin light-chain (AL) amyloidosis and has been associated with mortality and impaired quality of life (QoL). We investigated whether nutritional counseling is beneficial to the maintenance of nutritional status and QoL in AL outpatients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Pavia, 27100, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nutritional counseling consists in: personalized dietary prescription associated with regular (every 3 weeks) dietetic advise by a registered dietician. Follow-up evaluations take place also during the visits scheduled by the oncologists
General dietary advices are provided. Follow-up evaluations take place during the visits scheduled by the oncologists
Time frame: 12 months
Change in body weight at 12 months
Time frame: 12 months
Change in quality of life at 12 months
Time frame: 12 months
Overall survival at the end of study
Fondazione IRCCS Policlinico San Matteo di Pavia
Other
Nutritional Counseling in Systemic Immunoglobulin Light-chain (AL) Amyloidosis: a Prospective Randomized, Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01347047
Amyloidosis, Disease Attributes
Buenos Aires, Argentina
View Trial DetailsNCT06414746
Amyloidosis, Amyloidosis, Hereditary, Transthyretin-Related
Arkhangelsk, Russia
View Trial DetailsNCT03019029
Amyloidosis, Metabolic Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT03431896
AL Amyloidosis, Alzheimer Disease
Cleveland, Ohio, United States
View Trial Details